Kay Cox writes…
Four couples have been chosen to try Androferti – which has been tested in clinical trials to show it can improve sperm quality – on the 2015 Fertility Journey.
Each of them has had different degrees of assisted fertility treatments, varying sperm status, and have had their unique experiences of hope and heartbreak – but all of them share the same dream as everyone on a Fertility Journey.
It’s a tough road to travel, but here’s hoping that we can share their joy as they conceive.
Androferti has been brought to the UK by distributor Purple Orchid after being used across Europe for many years by couples trying to conceive spontaneously, and by those who want to increase their chances of success with assisted fertility treatment.
Nutrition and supplements are widely used to try to improve sperm quality, mostly based on research into individual ingredients. The clinical studies showing Androferti’s benefits are based on its unique formulation of minerals, vitamins and antioxidants which takes into account how those ingredients react with each other within the body.
Androferti has been shown to increase sperm count and concentration. It also improves the sperm’s ability to swim towards the egg and its capacity to fertilise it when it reaches it.
Sperm quality is also crucial. The sperm head can be damaged with tiny cavities called vacuoles, which have been associated with implantation failures and some forms of miscarriage. Spermatozoa are graded from I to IV with IV being the most vacuolated. A study of antioxidant therapy showed Androferti reduced the number of high grade (III and IV) vacuoles.
DNA damage can also be an issue – Androferti reduces the number of sperm with single DNA fragmentation, and the rate at which the DNA degenerates. This is especially helpful to fertility clinics because treatment with Androferti allows them to collect a sample from which there is a greater selection of high quality sperm, which can be preserved for longer before it is used, with greater resistance to freezing.
A key factor in Androferti’s formulation is the dose of L-carnitine, which improves sperm mobility – it contains less than in many products. Studies have shown that L-carnitine absorption reaches saturation point at 2g. When it has more than 2g, the body flushes it out faster than it absorbs it, so it ends up with less available to be used. Androferti has 1.5g to allow for L-carnitine found in food, and is taken twice a day because the level of it in the body diminishes over a 12-hour period, so it needs to be replenished.
Purple Orchid managing director Karen Gardiner says: “Purple Orchid carries forward a vision of empowering women to take care of themselves through their reproductive years from puberty through motherhood to menopause, providing a fertility range, chlamydia tests and effective, natural treatments for maintaining vaginal health, breastfeeding and urology. But fertility is an issue that couples face together. So now, with this groundbreaking men’s product, Androferti, we look forward to guiding these couples through their journeys in 2015 and beyond, and are thrilled to be working with Fertility Road on this project.”